Bionomics (BNOX) News Today → The most important AI company you've never heard of (From Manward Press) (Ad) Free BNOX Stock Alerts $0.92 -0.01 (-1.08%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 17, 2024 | finance.yahoo.comBionomics Limited (BNOX) Stock Historical Prices & Data - Yahoo FinanceMarch 27, 2024 | markets.businessinsider.comBuy Rating Affirmed for Bionomics’ BNC210 Following Promising PTSD Study ResultsMarch 21, 2024 | msn.comBionomics Reveals Detailed Data From PTSD Trial, Stock SoarsMarch 21, 2024 | globenewswire.comBionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress DisorderMarch 20, 2024 | finance.yahoo.comBionomics First Half 2024 Earnings: AU$1.62 loss per share (vs AU$2.16 loss in 1H 2023)February 22, 2024 | globenewswire.comBionomics to Present at the 2024 BIO CEO & Investor ConferenceFebruary 22, 2024 | benzinga.comBionomics Stock (NASDAQ:BNOX), Short Interest ReportJanuary 22, 2024 | finanznachrichten.deBionomics Ltd: Bionomics Provides a Review of 2023 and of 2024 PlansJanuary 22, 2024 | finance.yahoo.comBionomics Provides a Review of 2023 and of 2024 PlansDecember 7, 2023 | morningstar.comBionomics Ltd ADR BNOXDecember 6, 2023 | finance.yahoo.comBionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual MeetingDecember 4, 2023 | ca.finance.yahoo.comBionomics Limited (BNOX)October 19, 2023 | benzinga.comBionomics Meets The FDA: Lead Drug Candidate For Social Anxiety Heads To Phase 3October 3, 2023 | markets.businessinsider.comPromising Progress of BNC210 Bolsters Buy Rating on Bionomics Amidst Rising Interest in SAD TreatmentsSeptember 30, 2023 | finance.yahoo.comBionomics Full Year 2023 Earnings: AU$3.60 loss per share (vs AU$0.016 loss in FY 2022)September 29, 2023 | finance.yahoo.comBionomics (BNOX) Meets Goals in PTSD Study, Stock Rallies 244%September 29, 2023 | msn.comBionomics’ stock rallies 300% after company reports positive results in trial of PTSD treatmentSeptember 28, 2023 | markets.businessinsider.comBionomics' Victory - Analysts Note Optimism Around Promising Prospects for PTSD TreatmentSeptember 28, 2023 | finance.yahoo.comBionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)September 28, 2023 | msn.comWhy Is Stress Disorder Focused Bionomics Stock Trading Higher Today?September 28, 2023 | investorplace.comWhy Is Bionomics (BNOX) Stock Up 347% Today?September 4, 2023 | nasdaq.comBionomics Limited American Depository Shares (BNOX)July 31, 2023 | finanznachrichten.deBionomics Ltd: Quarterly Activities and Cashflow ReportJuly 24, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 06:07 AM with a stated reason of "News pending."June 15, 2023 | finance.yahoo.comBionomics to Present at Upcoming June Investor ConferencesMay 30, 2023 | finance.yahoo.comBionomics Announces Upcoming Poster Presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual MeetingMarch 9, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Hold Rating on Bionomics (BNOX)March 9, 2023 | finance.yahoo.comBionomics Reveals Detailed Data From Its Flunked Anxiety Trial, Shows Reductions In Anxiety Across Multiple PhasesMarch 8, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 11:03 AM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 12:03 PM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 12:03 PM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 11:03 AM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 11:03 AM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 11:03 AM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 11:03 AM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:03 AM with a stated reason of "LULD pause."March 7, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:03 AM with a stated reason of "LULD pause."March 6, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:03 AM with a stated reason of "LULD pause."February 23, 2023 | finance.yahoo.comBionomics’ Half-Year ReportJanuary 30, 2023 | finance.yahoo.comQuarterly Activities and Cashflow ReportJanuary 24, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:01 AM with a stated reason of "LULD pause."January 24, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:01 AM with a stated reason of "LULD pause."January 23, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 11:01 AM with a stated reason of "LULD pause."January 13, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:01 AM with a stated reason of "LULD pause."January 11, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 10:01 AM with a stated reason of "LULD pause."January 11, 2023 | marketbeat.comTrading was temporarily halted for "BNOX" at 09:01 AM with a stated reason of "LULD pause."December 21, 2022 | finanznachrichten.deBionomics Ltd: Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety DisorderDecember 19, 2022 | finance.yahoo.comBionomics' Social Anxiety Disorder Study Fails To Meet Primary EndpointDecember 19, 2022 | markets.businessinsider.comBionomics' BNC210 Phase 2 Study In Social Anxiety Disorder Fails To Meet Primary GoalDecember 2, 2022 | finance.yahoo.comBionomics Announces Accepted Abstract and Upcoming Poster Presentations at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting Get Bionomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address The most important AI company you've never heard of (Ad)Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products. Get the full story on this secret AI company poised for massive growth BNOX Media Mentions By Week BNOX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNOX News Sentiment▼1.580.55▲Average Medical News Sentiment BNOX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNOX Articles This Week▼30▲BNOX Articles Average Week Get Bionomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VIRI News Today CYCN News Today CVKD News Today TRVN News Today NCNA News Today VCNX News Today EFTR News Today BFRI News Today HEPA News Today UPC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNOX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
